2021
DOI: 10.1001/jamahealthforum.2021.0105
|View full text |Cite
|
Sign up to set email alerts
|

Allocating COVID-19 Vaccines Globally: An Urgent Need

Abstract: The first coronavirus disease 2019 (COVID-19) vaccines have undergone regulatory approvals in highincome countries. Vaccine producers are delivering the orders they received months ago, prepaid at a price that would guarantee buyers to be first in line. Vaccination campaigns are already underway in these high-income countries. Leaders of the European Commission,

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 3 publications
1
16
0
Order By: Relevance
“…The pandemic has affected low-resource settings severely and is compounded by the lack of vaccine availability in the majority of LMICs (50). The pandemic exacerbated hospitals in low-resource settings, as many hospital systems were overwhelmed with the exponentially increasing volumes of COVID patients without the infrastructure to support these patients or provide the necessary care to treat them.…”
Section: Weaknessesmentioning
confidence: 99%
“…The pandemic has affected low-resource settings severely and is compounded by the lack of vaccine availability in the majority of LMICs (50). The pandemic exacerbated hospitals in low-resource settings, as many hospital systems were overwhelmed with the exponentially increasing volumes of COVID patients without the infrastructure to support these patients or provide the necessary care to treat them.…”
Section: Weaknessesmentioning
confidence: 99%
“…[ 55 ] Scientific evidence available has shown that better economic and health outcomes by adopting a cooperative, equitable, and fair distribution of COVID-19 vaccines on a global scale. [ 56 ]…”
Section: Onclusionsmentioning
confidence: 99%
“…While there are now several highly efficacious vaccines to prevent severe disease 12 , 13 , and possibly infection 14 , 15 , from SARS-CoV-2 (the virus that causes COVID-19), widespread vaccination will take months to years 16 , 17 and will likely need to be coupled with effective non-pharmaceutical interventions (NPIs) 18 . For countries rolling out vaccines, easing NPIs too early could jeopardize success 18 .…”
Section: Introductionmentioning
confidence: 99%
“…For countries rolling out vaccines, easing NPIs too early could jeopardize success 18 . However, for the majority of the world's population, particularly those living in LMIC, vaccine access and delivery is limited 19 and widespread vaccination coverage may take two or more years 17 , 20 . Thus, with or without vaccines, understanding the effectiveness of NPIs that can curtail COVID-19 transmission is critical.…”
Section: Introductionmentioning
confidence: 99%